Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CYTOKINETICS INC Director's Dealing 2021

Mar 13, 2021

30870_dirs_2021-03-12_87dc629b-36cc-479c-8ea5-7881ae737a80.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTOKINETICS INC (CYTK)
CIK: 0001061983
Period of Report: 2021-03-12

Reporting Person: GAGE L PATRICK (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-03-12 Common Stock M 7006 $5.88 Acquired 28768 Direct
2021-03-12 Common Stock S 7006 $21.2179 Disposed 21762 Direct
2021-03-12 Common Stock M 3333 $8.64 Acquired 25095 Direct
2021-03-12 Common Stock S 3333 $21.2179 Disposed 21762 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-03-12 Non-Qualified Stock Option (right to buy) $5.88 M 7006 Disposed 2022-01-03 Common Stock (7006) Direct
2021-03-12 Non-Qualified Stock Option (right to buy) $8.64 M 3333 Disposed 2021-05-18 Common Stock (3333) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 1850 Indirect